Company intelligence / Profile preview

MMCAP International

Grand Cayman, Cayman Islands

Ownership: Private
Development stage: Other

Overview

MMCAP International is a Cayman Islands-based investment firm structured as a segregated portfolio company rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly available records identify it as an active fund manager and SEC filer with a substantial publicly disclosed equities portfolio. While the firm has participated in some healthcare- and life-science-related financings as an investor, it does not appear to develop drugs, diagnostics, medical devices, or healthcare services itself. Accordingly, it should be classified as a financial investor, not a life sciences company.

Industry: Investors

Beyond the preview

Go deeper on MMCAP International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MMCAP International.

Explore the full profile